CN Patent

CN121127476A — 多环吡啶酮衍生物及其用途

Assigned to CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd · Expires 2025-12-12 · 0y expired

What this patent protects

本发明提供一类多环吡啶酮类衍生物、其组合物及用途。本发明的化合物对流感病毒具有抑制作用，可治疗帽依赖性核酸内切酶介导的疾病。

USPTO Abstract

本发明提供一类多环吡啶酮类衍生物、其组合物及用途。本发明的化合物对流感病毒具有抑制作用，可治疗帽依赖性核酸内切酶介导的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN121127476A
Jurisdiction
CN
Classification
—
Expires
2025-12-12
Drug substance claim
No
Drug product claim
No
Assignee
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.